Does anyone have an idea of exactly when these presentations will begin? I emailed the company well over a week ago, and no response. Also asked the question about further data from the Rwanda trial being released - no answer as well.
If you check the WHO website on info for prequalified medicines, it is clear that a small trial of 30 patients was never going to be enough to apply for prequalification.
I guess the purpose of the IIa trial was to establish if the project is actually viable - which it seems it is.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EMS (ASX) Chart |
Day chart unavailable